Artificial Intelligence in Prostate Cancer Diagnosis on Magnetic Resonance Imaging: Time for a New PARADIGM.

Journal: European urology
Published Date: Apr 30, 2025

Abstract

Artificial intelligence (AI) may provide a solution for improving access to expert, timely, and accurate magnetic resonance imaging (MRI) interpretation. The PARADIGM trial will provide level 1 evidence on the role of AI in the diagnosis of prostate cancer on MRI.

Authors

  • Alexander Bcd Ng
    Division of Surgery and Interventional Science, University College London, London, UK; Centre for Urology Imaging, Prostate, AI and Surgical Studies (COMPASS) Research Group, University College London, London, UK.
  • Francesco Giganti
    Department of Radiology, University College London Hospital, London, UK.
  • Veeru Kasivisvanathan
    Department of Urology, Guy's Hospital, London, UK; Division of Surgery, University College London, London, UK.

Keywords

External Resources

Popular Topics
Recent Journals